Value Investing
Value Investing Articles
The financial services sector was one of the biggest beneficiaries of the Trump bump. But things are different now, right before the slow summer months.
Published:
Last Updated:
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Published:
Last Updated:
Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just assumed this was a takeover or that the company had major news shaking the...
Published:
Last Updated:
While investors love companies with high dividend yields and those that can be expected to raise dividends in the future, there is a dark side of dividend investing.
Published:
Last Updated:
Here are five of the top picks from Jefferies in which the firm's own analysts expect upside of 25% or more while simultaneously seeing limited downside from the current share price.
Published:
Last Updated:
Merrill Lynch resumed coverage of Noble Energy with a price objective that indicates more than 50% in implied upside for investors.
Published:
Last Updated:
These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19, 2017 -- plus a bonus that may as well have been a downgrade to Sell.
Published:
Last Updated:
Exxon Mobil was reiterated as Buy and on the Focus List at Argus, along with a price target of $104. If the firm is proven to be right, Exxon investors would see a total return of about 30% over the...
Published:
Last Updated:
What may have saved the day for Pandora is a board change, an outside investment commitment from KKR and possibly being a buyout target.
Published:
Last Updated:
First Solar was a winner in the days ahead of earnings, and Wednesday has proven to be a big post-earnings win for the leader of U.S. solar power. But are analysts upgrading First Solar for the right...
Published:
Last Updated:
Many value investors have flocked to Gilead Sciences as the world's top biotech stock now that it is valued at a lower multiple than Big Pharma rivals.
Published:
Last Updated:
If you have followed the dust cloud of failed mergers over the years, chances are high that you know the saga of the failed merger between Staples, Inc. (NASDAQ: SPLS) and Office Depot Inc. (NASDAQ:...
Published:
Last Updated:
As of the start of May of 2017, just 21 members of the S&P 500 Index were valued at less than 10 times expected earnings per share.
Published:
Last Updated:
Here are seven very speculative analyst stock picks recently called to rise 100% or exponentially in 2017 or into 2018.
Published:
Last Updated:
Some sell-offs come out of thin air for reasons that most investors had not considered. Maybe it is time for investors to reconsider all of the growth-chasing in favor of some of the safer...
Published:
Last Updated: